Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report - (Investor's Business Daily via NewsPoints Desk)

  • According to a report, Amgen is nearing a massive deal to purchase Alexion Pharmaceuticals at a 74% premium, Investor's Business Daily reported Thursday.

  • Mizuho Securities analyst Salim Syed stated that Amgen is "in the final stretch to buy Alexion" for $200 per share.

  • Syed, who suggested that potential deal could be highly accretive to Amgen, remarked "the concept of this happening doesn't sound too crazy to me."

  • The analyst noted that Alexion was the most cited takeover target for Amgen in an investor survey conducted earlier this year.

  • "The mood here is reading similar to Gilead Sciences and [Kite Pharma]," commented Syed, noting that it is "getting very quiet…and that deal was announced in the last week of August 2017."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles